Circulation · 2016 · 365 citations · 37 references
MedicineCardiologySurgeryCardiothoracic SurgeryPerioperative Outcomes ResearchReconstructive SurgeryCardiac Valve SurgeryMitral RegurgitationMitral Valve DiseaseMitral Valve InterventionPrognosis AssessmentTreatment Outcome EvaluationFlail Mitral Valve LeafletInverse Probability WeightingMitral Valve Leaflet ProlapseOperative MorbidityPropensity Score AdjustmentSurgical Mitral Valve ReplacementValve Replacement Indications
BACKGROUND: Mitral valve (MV) repair is preferred over replacement in clinical guidelines and is an important determinant of the indication for surgery in degenerative mitral regurgitation. However, the level of evidence supporting current recommendations is low, and recent data cast doubts on its validity in the current era. Accordingly, the aim of the present study was to analyze very long-term outcome after MV repair and replacement for degenerative mitral regurgitation with a flail leaflet. METHODS: MIDA (Mitral Regurgitation International Database) is a multicenter registry enrolling patients with degenerative mitral regurgitation with a flail leaflet in 6 tertiary European and US centers. We analyzed the outcome after MV repair (n=1709) and replacement (n=213) overall, by propensity score matching, and by inverse probability-of-treatment weighting. RESULTS: At baseline, patients undergoing MV repair were younger, had more comorbidities, and were more likely to present with a posterior leaflet prolapse than those undergoing MV replacement. After propensity score matching and inverse probability-of-treatment weighting, the 2 treatments groups were balanced, and absolute standardized differences were usually <10%, indicating adequate match. Operative mortality (defined as a death occurring within 30 days from surgery or during the same hospitalization) was lower after MV repair than after replacement in both the entire population (1.3% versus 4.7%; P<0.001) and the propensity-matched population (0.2% versus 4.4%; P<0.001). During a mean follow-up of 9.2 years, 552 deaths were observed, of which 207 were of cardiovascular origin. Twenty-year survival was better after MV repair than after MV replacement in both the entire population (46% versus 23%; P<0.001) and the matched population (41% versus 24%; P<0.001). Similar superiority of MV repair was obtained in patient subsets on the basis of age, sex, or any stratification criteria (all P<0.001). MV repair was also associated with reduced incidence of reoperations and valve-related complications. CONCLUSIONS: Among patients with degenerative mitral regurgitation with a flail leaflet referred to mitral surgery, MV repair was associated with lower operative mortality, better long-term survival, and fewer valve-related complications compared with MV replacement.
37
Burden of valvular heart diseases: a population-based study
Vuyisile T. Nkomo, Julius M. Gardin, Thomas N. Skelton et al. · The Lancet · 2006 · 4.8K citations
William A. Zoghbi, Maurice Enriquez‐Sarano, Elyse Foster et al. · Journal of the American Society of Echocardiography · 2003 · 4.1K citations · Full text
Medicine, Cardiology, Surgery +14
Guidelines on the management of valvular heart disease (version 2012)
Alec Vahanian, Ottavio Alfieri, Felicita Andreotti et al. · European Heart Journal · 2012 · 3.6K citations · Full text
Medicine, Cardiology, Surgery +14